Metraipolis › archive › dc_347d2f83e71a

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40286311
DOI
10.1093/rheumatology/keaf232
License (as archived)
solo-consultazione
Archived
2026-11-10T05:47:24.757Z
SHA-256 of the archived text
7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148
Stable URL of this page
https://metraipolis.com/documento/dc_347d2f83e71a

How to cite

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311 — Europe PMC (en), https://europepmc.org/article/MED/40286311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_347d2f83e71a (Metraipolis archive dc_347d2f83e71a, sha256 7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148)
BibTeX
@misc{dc347d2f83e71a,
  title = {Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40286311},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_347d2f83e71a; sha256 7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40286311. Agents can read the archived copy with the MCP tool read_document.